“Hook effect and serum KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)”, IJIHS, vol. 9, no. 2, pp. 66–72, Oct. 2021, doi: 10.15850/ijihs.v9n2.2488.